𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference

✍ Scribed by Giuseppe Sautto; Nicasio Mancini; Roberta A. Diotti; Laura Solforosi; Massimo Clementi; Roberto Burioni

Book ID
119190607
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
792 KB
Volume
96
Category
Article
ISSN
0166-3542

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Modulation of epitope-specific anti-hepa
Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment
✍ Nicasio Mancini; Silvia Carletti; Mario Perotti; Luisa RomanΓ²; Rosellina Di Stef πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 261 KB

## Abstract The dynamic features of three specific anti‐hepatitis C virus (HCV) antibody subpopulations directed against different conformational epitopes of the viral E2 protein (HCV/E2) have been evaluated in patients with primary and persistent HCV infection; the three subpopulations are present

Human monoclonal antibodies that react w
Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity
✍ Darren J. Schofield; Birke Bartosch; Yohko K. Shimizu; Tobias Allander; Harvey J πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 187 KB

Active and/or passive immunoprophylaxis against hepatitis C virus (HCV) remain unachieved goals. Monoclonal antibodies might provide one approach to protection. We derived human monoclonal antibodies from the bone marrow of a patient with a well-controlled HCV infection of 22 years duration. Five di